Catalyst Wire Dossier Catalyst Wire Dossier

anti-von Willebrand Factor nanobody

· Ablynx (a Sanofi company)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for anti-von Willebrand Factor nanobody, covering 2019-05-29 to 2019-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) [Phase 2]

See pricing